BTIG analyst Ryan Zimmerman trimmed Stryker's price target from $416 to $403, but still slapped on a Buy rating like a Band-Aid. This cut reflects broader jitters in the MedTech sector, especially ...

Alonso Martínez continues to be one of the biggest success stories in MLS. Since moving from the wing to the striker spot ...

BTIG analyst Ryan Zimmerman lowered the firm’s price target on GE HealthCare (GEHC) to $95 from $103 and keeps a Buy rating on the shares as ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...